Publication | Closed Access
Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial
54
Citations
17
References
2009
Year
UrologyPhase Ii TrialMedicinePharmacologyPharmacotherapyAnti-cancer AgentCancer TreatmentProstatic DiseaseOncologyMolecular OncologyFinal Results
| Year | Citations | |
|---|---|---|
Page 1
Page 1